NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 20 filers reported holding NEMAURA MED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,116 | -74.0% | 3,542 | -23.7% | 0.00% | – |
| Q2 2023 | $4,296 | -85.4% | 4,643 | -85.8% | 0.00% | – |
| Q1 2023 | $29,333 | -46.4% | 32,774 | +2.8% | 0.00% | – |
| Q4 2022 | $54,731 | -15.8% | 31,874 | +1.9% | 0.00% | – |
| Q3 2022 | $65,000 | -21.7% | 31,274 | -2.3% | 0.00% | – |
| Q2 2022 | $83,000 | -41.5% | 32,024 | -1.4% | 0.00% | – |
| Q1 2022 | $142,000 | -8.4% | 32,474 | -4.0% | 0.00% | – |
| Q4 2021 | $155,000 | -26.2% | 33,824 | -2.8% | 0.00% | – |
| Q3 2021 | $210,000 | -42.6% | 34,797 | -1.8% | 0.00% | – |
| Q2 2021 | $366,000 | -87.3% | 35,449 | -90.6% | 0.00% | – |
| Q1 2021 | $2,892,000 | +109.6% | 378,567 | +3.4% | 0.00% | – |
| Q4 2020 | $1,380,000 | +13.0% | 366,195 | +6.5% | 0.00% | – |
| Q3 2020 | $1,221,000 | -61.5% | 343,924 | +0.2% | 0.00% | – |
| Q2 2020 | $3,172,000 | – | 343,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,842,565 | $580,408 | 0.00% |
| VANGUARD GROUP INC | 126,682 | $39,905 | 0.00% |
| UBS Group AG | 85 | $27 | 0.00% |
| NewEdge Advisors, LLC | 360 | $113 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $158 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,158 | $1,310 | 0.00% |
| NORTHERN TRUST CORP | 26,737 | $8,422 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $34,829 | 0.00% |